If confirmed, this may be a possible explanation for the contradictory growth-promoting effects evidenced in several cancer types, but not in RCC, in which GFRAL presence is decreased and in which GDF-15 rather inhibits progression. This evidence concerns the gene GFRAL and renal cell carcinoma.